Statement of Changes in Beneficial Ownership (4)

FORM 4

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL

OMB Number:

3235-0287

Estimated average burden
hours per response...

0.5

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person * Irwin & Joan Jacobs Trust Dated 6-2-80	2. Issuer Name and Ticker or Trading Symbol DermTech, Inc. [ DMTK ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director                    __X__ 10% Owner _____ Officer (give title below)    _____ Other (specify below)
(Last)          (First)          (Middle) 2710 IVERNESS COURT	3. Date of Earliest Transaction (MM/DD/YYYY) 5/11/2020
(Street) LA JOLLA, CA 92037 (City)        (State)        (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) ___ Form filed by One Reporting Person _ X _ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	5/11/2020		X		41932	A	$9.54	1808434	D (1)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Warrant (right to buy)	$9.54	5/11/2020		X			41932	5/11/2017	5/11/2020	Common Stock	41932	$0.00	0	D (1)

Explanation of Responses:
(1)	These securities are directly owned by the Irwin & Joan Jacobs Trust Dated 6-2-80. Irwin Jacobs and Joan Jacobs are the trustees of the Irwin & Joan Jacobs Trust Dated 6-2-80 and, in such capacity, may each be deemed to indirectly beneficially own the securities owned by the Irwin & Joan Jacobs Trust Dated 6-2-80.

Reporting Owners
Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Irwin & Joan Jacobs Trust Dated 6-2-80 2710 IVERNESS COURT LA JOLLA, CA 92037		X
JACOBS IRWIN M 2710 IVERNESS COURT LA JOLLA, CA 92037		X
Jacobs Joan 2710 IVERNESS COURT LA JOLLA, CA 92037		X

Signatures
Jason S. Miller, as attorney-in-fact to the Irwin & Joan Jacobs Trust Dated 6-2-80		5/13/2020
**Signature of Reporting Person		Date
Jason S. Miller, as attorney-in-fact to Irwin Jacobs		5/13/2020
**Signature of Reporting Person		Date
Jason S. Miller, as attorney-in-fact to Joan Jacobs		5/13/2020
**Signature of Reporting Person		Date